A detailed history of Victory Capital Management Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 96,609 shares of REGN stock, worth $69 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
96,609
Previous 98,882 2.3%
Holding current value
$69 Million
Previous $104 Million 2.28%
% of portfolio
0.1%
Previous 0.11%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$1024.09 - $1201.76 $2.33 Million - $2.73 Million
-2,273 Reduced 2.3%
96,609 $102 Million
Q2 2024

Aug 05, 2024

SELL
$883.2 - $1071.19 $204,902 - $248,516
-232 Reduced 0.23%
98,882 $104 Million
Q1 2024

May 03, 2024

BUY
$902.69 - $993.35 $5.62 Million - $6.18 Million
6,223 Added 6.7%
99,114 $95.4 Million
Q4 2023

Feb 05, 2024

BUY
$775.18 - $881.7 $3.08 Million - $3.51 Million
3,977 Added 4.47%
92,891 $81.6 Million
Q3 2023

Nov 06, 2023

BUY
$692.45 - $844.37 $7.87 Million - $9.6 Million
11,370 Added 14.66%
88,914 $73.2 Million
Q2 2023

Jul 27, 2023

SELL
$700.03 - $830.35 $26 Million - $30.8 Million
-37,109 Reduced 32.37%
77,544 $55.7 Million
Q1 2023

May 02, 2023

BUY
$680.49 - $826.97 $16.6 Million - $20.1 Million
24,362 Added 26.98%
114,653 $94.2 Million
Q4 2022

Feb 10, 2023

BUY
$705.89 - $766.39 $7.61 Million - $8.26 Million
10,780 Added 13.56%
90,291 $65.1 Million
Q4 2022

Feb 09, 2023

SELL
$705.89 - $766.39 $8.79 Million - $9.55 Million
-12,459 Reduced 13.55%
79,511 $57.4 Million
Q3 2022

Nov 02, 2022

BUY
$573.97 - $724.32 $8.38 Million - $10.6 Million
14,603 Added 18.87%
91,970 $63.4 Million
Q2 2022

Aug 01, 2022

SELL
$548.35 - $738.84 $8.77 Million - $11.8 Million
-15,987 Reduced 17.13%
77,367 $45.7 Million
Q1 2022

May 04, 2022

BUY
$595.12 - $698.43 $1.36 Million - $1.59 Million
2,281 Added 2.5%
93,354 $61.5 Million
Q4 2021

Feb 07, 2022

BUY
$543.48 - $670.97 $1.75 Million - $2.16 Million
3,219 Added 3.66%
91,073 $57.5 Million
Q3 2021

Nov 02, 2021

BUY
$574.03 - $680.96 $2.17 Million - $2.57 Million
3,780 Added 4.5%
87,854 $53.2 Million
Q2 2021

Aug 03, 2021

BUY
$472.8 - $558.54 $431,666 - $509,947
913 Added 1.1%
84,074 $47 Million
Q1 2021

May 04, 2021

SELL
$446.73 - $548.2 $1.82 Million - $2.23 Million
-4,063 Reduced 4.66%
83,161 $39.3 Million
Q4 2020

Feb 01, 2021

BUY
$478.3 - $607.98 $922,640 - $1.17 Million
1,929 Added 2.26%
87,224 $42.1 Million
Q3 2020

Nov 09, 2020

BUY
$544.75 - $658.21 $1.74 Million - $2.1 Million
3,188 Added 3.88%
85,295 $47.7 Million
Q2 2020

Aug 07, 2020

BUY
$493.32 - $643.92 $2.86 Million - $3.73 Million
5,797 Added 7.6%
82,107 $51.2 Million
Q1 2020

May 04, 2020

SELL
$336.18 - $494.43 $2.66 Million - $3.91 Million
-7,917 Reduced 9.4%
76,310 $37.3 Million
Q4 2019

Feb 06, 2020

SELL
$274.13 - $376.51 $2.72 Million - $3.73 Million
-9,912 Reduced 10.53%
84,227 $31.6 Million
Q4 2019

Feb 04, 2020

BUY
$274.13 - $376.51 $9.62 Million - $13.2 Million
35,098 Added 59.45%
94,139 $31.8 Million
Q3 2019

Nov 12, 2019

BUY
$273.46 - $318.39 $14 Million - $16.3 Million
51,100 Added 643.5%
59,041 $16.4 Million
Q2 2019

Aug 15, 2019

BUY
$299.6 - $414.82 $11,384 - $15,763
38 Added 0.48%
7,941 $2.49 Million
Q1 2019

May 03, 2019

SELL
$372.08 - $439.57 $318,500 - $376,271
-856 Reduced 9.77%
7,903 $3.25 Million
Q4 2018

Feb 05, 2019

SELL
$335.82 - $403.04 $8,731 - $10,479
-26 Reduced 0.3%
8,759 $3.27 Million
Q3 2018

Nov 01, 2018

BUY
$351.14 - $408.51 $110,609 - $128,680
315 Added 3.72%
8,785 $3.55 Million
Q2 2018

Aug 02, 2018

BUY
$284.6 - $344.99 $237,641 - $288,066
835 Added 10.94%
8,470 $2.92 Million
Q1 2018

May 04, 2018

BUY
$315.82 - $393.78 $1.2 Million - $1.49 Million
3,794 Added 98.78%
7,635 $2.63 Million
Q4 2017

Feb 01, 2018

BUY
$358.63 - $469.95 $82,126 - $107,618
229 Added 6.34%
3,841 $1.44 Million
Q3 2017

Oct 27, 2017

SELL
$431.38 - $504.0 $150,983 - $176,400
-350 Reduced 8.83%
3,612 $1.62 Million
Q2 2017

Aug 07, 2017

BUY
N/A
3,962
3,962 $1.95 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.